Ask Warren

Kainos Medicine

284620 · KOSDAQ · ₩284620 · 카이노스메드

₩1,087 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩408M₩370M₩304M₩322M₩176M₩369M₩71M₩204M
Cost of sales₩104M₩94M₩757M₩81M₩49M₩84M₩38M₩52M
Gross profit₩304M₩276M−₩453M₩241M₩127M₩285M₩34M₩152M
Operating income−₩1.1B−₩1B−₩2.3B−₩1.5B−₩945M−₩1.7B−₩4.2B−₩2.4B
Net income−₩15M−₩1.3B−₩5.9B₩74M₩250M−₩2.2B−₩9.8B₩606M
Net income to shareholders−₩1.3B−₩1.3B−₩1.9B−₩1.8B−₩1.9B−₩2.2B−₩4.2B−₩2.4B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩4.2B₩5.6B₩6.6B₩9.8B₩12B₩13B₩11B₩14B
Current assets₩2.3B₩3.5B₩4.4B₩5.6B₩7.1B₩7.8B₩4.6B₩10B
Cash and equivalents₩673M₩1.8B₩2.9B₩4.2B₩4.7B₩6.4B₩3.8B₩8.2B
Total liabilities₩2B₩2.2B₩2B₩4.1B₩4.2B₩3.9B₩4.9B₩4.4B
Current liabilities₩2B₩2.2B₩2B₩4.1B₩4.1B₩3.8B₩4.7B₩4.2B
Borrowings——————₩0—
Total equity₩2.2B₩3.4B₩4.6B₩5.6B₩7.4B₩9.5B₩5.9B₩10B
Shareholders' equity−₩1.3B−₩41M₩1.1B₩2.2B₩3.3B₩5.4B₩1.8B₩6B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩1.1B−₩862M−₩1.3B−₩480M−₩1.1B−₩3B−₩1.8B−₩2.7B
Capital spending——₩0₩2.1M——₩0₩0
Free cash flow−₩1.1B−₩862M−₩1.3B−₩482M−₩1.1B−₩3B−₩1.8B−₩2.7B

Consolidated where available. Amounts in won.

Also known as: Kainos Medicine / 카이노스메드 / 284620 / KRX:284620

Source: KRX statistical information